Marta Varela-Eirin

Marta Varela-Eirin

Auto-generated profile, based on publicly available information

Marta Varela-Eirin

CellCOM Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Servizo Galego de Saúde (SERGAS), Universidade da Coruña (UDC), A Coruña, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Ageing Research Reviews
Verified
Journal Article
Closed access
MVMarta Varela-Eirin
Marta Varela-Eirin
JLJesus Loureiro
Jesus Loureiro
EFEduardo Fonseca
Eduardo Fonseca
SCSilvia Corrochano
Silvia Corrochano
JCJose R. Caeiro
Jose R. Caeiro
MMMaria D. Mayan
Maria D. Mayan

5 January 2022 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
Boshi WangBoshi Wang
Boshi Wang
MVMarta Varela‐Eirin
Marta Varela‐Eirin
SBSimone M Brandenburg
Simone M Brandenburg
AHAlejandra Hernandez‐Segura
Alejandra Hernandez‐Segura
TVThijmen van Vliet
Thijmen van Vliet
MDMarco Demaria
Marco Demaria
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

5 December 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MVMarta Varela-Eirín
Marta Varela-Eirín
AVAdrián Varela-Vázquez
Adrián Varela-Vázquez
AGAmanda Guitián-Caamaño
Amanda Guitián-Caamaño
CPCarlos Luis Paíno
Carlos Luis Paíno
VMVirginia Mato
Virginia Mato
MMMaria D. Mayan
Maria D. Mayan
Osteoarthritis (OA), a chronic disease characterized by articular cartilage degeneration, is a leading cause of disability and pain worldwide. In OA, chondrocytes in cartilage undergo phenotypic changes and senescence, restricting cartilage regeneration and favouring disease progression. Similar to other wound-healing disorders, chondrocytes from OA patients show a chronic increase in the gap junction channel protein connexin43 (Cx43), which regulates signal transduction through the exchange of elements or recruitment/release of signalling factors. Although immature or stem-like cells are present in cartilage from OA patients, their origin and role in disease progression are unknown. In this study, we found that Cx43 acts as a positive regulator of chondrocyte-mesenchymal transition. Overactive Cx43 largely maintains the immature phenotype by increasing nuclear translocation of Twist-1 and tissue remodelling and proinflammatory agents, such as MMPs and IL-1β, which in turn cause cellular senescence through upregulation of p53, p16 INK4a and NF-κB, contributing to the senescence-associated secretory phenotype (SASP). Downregulation of either Cx43 by CRISPR/Cas9 or Cx43-mediated gap junctional intercellular communication (GJIC) by carbenoxolone treatment triggered rediferentiation of osteoarthritic chondrocytes into a more differentiated state, associated with decreased synthesis of MMPs and proinflammatory factors, and reduced senescence. We have identified causal Cx43-sensitive circuit in chondrocytes that regulates dedifferentiation, redifferentiation and senescence. We propose that chondrocytes undergo chondrocyte-mesenchymal transition where increased Cx43-mediated GJIC during OA facilitates Twist-1 nuclear translocation as a novel mechanism involved in OA progression. These findings support the use of Cx43 as an appropriate therapeutic target to halt OA progression and to promote cartilage regeneration.

5 August 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MVMarta Varela-Eirín
Marta Varela-Eirín
PCPaula Carpintero-Fernández
Paula Carpintero-Fernández
AGAmanda Guitián-Caamaño
Amanda Guitián-Caamaño
AVAdrián Varela-Vázquez
Adrián Varela-Vázquez
AGAlejandro García-Yuste
Alejandro García-Yuste
MMMaria D. Mayan
Maria D. Mayan
The accumulation of senescent cells is a key characteristic of aging, leading to the progression of age-related diseases such as osteoarthritis (OA). Previous data from our laboratory has demonstrated that high levels of the transmembrane protein connexin 43 (Cx43) are associated with a senescent phenotype in chondrocytes from osteoarthritic cartilage. OA has been reclassified as a musculoskeletal disease characterized by the breakdown of the articular cartilage affecting the whole joint, subchondral bone, synovium, ligaments, tendons and muscles. However, the mechanisms that contribute to the spread of pathogenic factors throughout the joint tissues are still unknown. Here, we show for the first time that small extracellular vesicles (sEVs) released by human OA-derived chondrocytes contain high levels of Cx43 and induce a senescent phenotype in targeted chondrocytes, synovial and bone cells contributing to the formation of an inflammatory and degenerative joint environment by the secretion of senescence-associated secretory associated phenotype (SASP) molecules, including IL-1ß and IL-6 and MMPs. The enrichment of Cx43 changes the protein profile and activity of the secreted sEVs. Our results indicate a dual role for sEVs containing Cx43 inducing senescence and activating cellular plasticity in target cells mediated by NF-kß and the extracellular signal-regulated kinase 1/2 (ERK1/2), inducing epithelial-to-mesenchymal transition (EMT) signalling programme and contributing to the loss of the fully differentiated phenotype. Our results demonstrated that Cx43-sEVs released by OA-derived chondrocytes spread senescence, inflammation and reprogramming factors involved in wound healing failure to neighbouring tissues, contributing to the progression of the disease among cartilage, synovium, and bone and probably from one joint to another. These results highlight the importance for future studies to consider sEVs positive for Cx43 as a new biomarker of disease progression and new target to treat OA.

1 April 2017 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Open access
MVMarta Varela-Eirin
Marta Varela-Eirin
AVAdrian Varela-Vazquez
Adrian Varela-Vazquez
MMMarina Rodríguez-Candela Mateos
Marina Rodríguez-Candela Mateos
AVAnton Vila-Sanjurjo
Anton Vila-Sanjurjo
EFEduardo Fonseca
Eduardo Fonseca
MMMaria D. Mayan
Maria D. Mayan
Connexins (Cxs) are integral membrane proteins that form high-conductance plasma membrane channels, allowing communication from cell to cell (via gap junctions) and from cells to the extracellular environment (via hemichannels). Initially described for their role in joining excitable cells (nerve and muscle), gap junctions (GJs) are found between virtually all cells in solid tissues and are essential for functional coordination by enabling the direct transfer of small signalling molecules, metabolites, ions, and electrical signals from cell to cell. Several studies have revealed diverse channel-independent functions of Cxs, which include the control of cell growth and tumourigenicity. Connexin43 (Cx43) is the most widespread Cx in the human body. The myriad roles of Cx43 and its implication in the development of disorders such as cancer, inflammation, osteoarthritis and Alzheimer's disease have given rise to many novel questions. Several RNA- and DNA-binding motifs were predicted in the Cx43 and Cx26 sequences using different computational methods. This review provides insights into new, ground-breaking functions of Cxs, highlighting important areas for future work such as transfer of genetic information through extracellular vesicles. We discuss the implication of potential RNA- and DNA-binding domains in the Cx43 and Cx26 sequences in the cellular communication and control of signalling pathways.

22 September 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
RGRaquel Gago-Fuentes
Raquel Gago-Fuentes
JBJohn F. Bechberger
John F. Bechberger
MVMarta Varela-Eirin
Marta Varela-Eirin
AVAdrian Varela-Vazquez
Adrian Varela-Vazquez
BABenigno Acea
Benigno Acea
MMMaria D. Mayan
Maria D. Mayan
The C-terminal domain of connexin43 modulates cartilage structure via chondrocyte phenotypic changes